Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
This article is from
The Cancer Letter
archive.
Vol. 35 No. 9 | September 28, 2012
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Competition For Center Grants Higher In FY95, Kimes Tells BSC
November 25, 1994
TCL Archive
UICC Announces Four Grant award Programs
July 14, 1978
TCL Archive
NIH Cool On OIG, But the Awardees Love it, DeVita Says
October 17, 1986
TCL Archive
ODAC Rejects Amsacrine NDA, Renews Idarubicin
September 14, 1990
TCL Archive
Adamson Objects to IOM “Primrose Path of Centralization” In Report
March 3, 1989
TCL Archive
NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies
June 15, 1990